Cancer research has revolutionized how we combat this complex disease, with significant advancements in drugs, vaccines, and drug development processes. Targeted therapies, such as monoclonal antibodies and small-molecule inhibitors, are reshaping treatment by attacking specific cancer cells while minimizing damage to healthy tissues. Immunotherapy, including immune checkpoint inhibitors, has empowered the body’s immune system to combat tumors more effectively.
Cancer vaccines, both preventive and therapeutic, are gaining momentum. Preventive vaccines like HPV have shown success in reducing cervical cancer risks, while therapeutic vaccines aim to stimulate immune responses against existing tumors. Furthermore, innovative drug development strategies leverage precision medicine and AI-driven approaches to design tailored treatments, fostering hope for personalized cancer care.
With these advancements, cancer research continues to pave the way for transformative solutions that improve survival rates and quality of life for patients worldwide.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : A case-based approach using IMPeTUs criteria in FDG PET/CT reporting of multiple myeloma
Mudalsha Ravina, All India Institute of Medical Sciences, India
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Transforming cancer care: Innovations, integrations, and impact
Shayan Maqsood, Jamia Hamdard University, India
Title : Genetic and epigenetic alterations of SOX7 in multiple myeloma and allied neoplasms
Can Küçük, Dokuz Eylul University, Turkey
Title : Advanced nanoparticles, the hallmark of targeted drug delivery for osteosarcoma
Shayan Maqsood, Jamia Hamdard University, India